Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

U.S. Naval Hospital Guam Collects Convalescent Plasma from Sailors

Image of Technician takes notes next to convalescent plasma samples. U.S. Naval Hospital Guam Hospitalman Apprentice Rebekah Morrison records the weight of convalescent plasma units collected from Sailors who recovered from COVID-19. (U.S. Navy Photo by Jaciyn Matanane/Released)

The COVID-19 Convalescent Plasma Collection Program (CCP) is a Department of Defense effort to collect 10,000 units of convalescent plasma donated by members of the military community who have recovered from the disease. Convalescent plasma will be used to treat critically ill patients and to support the development of an effective treatment against the disease. Eligible donors should contact the Armed Services Blood Program at: https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx to find a complete list of available collection centers.

U.S. Naval Hospital Guam began collecting COVID-19 convalescent plasma (CCP) May 31 in support of the Department of Defense (DOD) effort to develop therapeutics to support active duty readiness.

USNH Guam coordinated a four-day evolution with Naval Base Guam at the hospital’s Armed Services Blood Bank Center to collect the CCP, which is the liquid part of blood from patients who have recovered from an infection. Recovered COVID-19 patients have virus-specific antibodies that may help those currently fighting COVID-19 recover and keep those who are moderately ill from becoming seriously ill. While there is currently no approved treatment for COVID-19, CCP has been successfully used to counter other viral infections and may help fight this new virus.

During the four-day event, CCP units were collected from 138 volunteers, all Sailors assigned to the aircraft carrier, USS Theodore Roosevelt, who have fully recovered from COVID-19. Their donations will help the larger effort of working towards a possible treatment for COVID-19 and may help others fight the disease.

“We had a 4-day window to recruit and screen volunteer donors, and to collect, manufacture, and test these products,” said Navy Lt. Cmdr. Stephanie Golla, USNH Guam Blood Bank Donor Center department head and Area Joint Blood program officer. “This resulted in the collection of over 200 convalescent plasma units that will be available for transfusion.”

USNH Guam screened all volunteer donors to determine whether they met the eligibility requirements outlined by the U.S. Food and Drug Administration. To be eligible, a donor must be in good health, fully recovered from COVID-19, and meet other specific criteria, such as having a documented positive test.

“We are grateful for their willingness to donate,” said Golla. “This would not have been possible without them.”

Golla expressed that the USS Theodore Roosevelt sailors, with their display of courage and mental fortitude in this endeavor, are exemplary models of our fighting force.

“It feels good to be a part of this process by having a purpose other than being quarantined,” said Navy Aviation Electronics Technician 2nd Class Charles Curry. “I feel grateful for the time USNH Guam staff have taken out of their lives to help us.”

USNH Guam collected CCP to serve in the production of antibody therapeutics and treatment for its service members and beneficiaries infected with the virus. DOD’s efforts to make treatment available at its health care facilities support its mission of a medically ready force.

“This process shows we are step a closer to home and ready to get back to a new normal,” said Curry.

You also may be interested in...

Article
Dec 16, 2020

DHA contributes to COVID-19 vaccine effort

Vaccine bottles

While Pfizer’s vaccine is being distributed to all U.S. jurisdictions for administration, several more candidates are in development and clinical trials continue to be conducted simultaneously with pharmaceutical partners.

Policy
Dec 7, 2020

Memorandum: Coronavirus Disease 2019 Vaccine Guidance

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Type: Memorandum
Video
Nov 27, 2020

MHS Minute: November 2020

Image of MHS Minute Carousel

During Warrior Care Month, we reflect on the strength and resilience of our nation's wounded, ill, and injured service members, and recognize the caregivers who support their recovery and rehabilitation.

Skip subpage navigation
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery